Philadelphia, Pennsylvania 19104


Purpose:

The objective of this study is to 1) evaluate the impact of a novel individualized care planning/ educational technology (the On Q Care Planning System or CPS) on oncology patient and provider knowledge, attitudes and beliefs about Non-Small Cell Lung Carcinoma (NSCLC) clinical trials, as well as 2) to evaluate the impact of the On Q CPS on patient referral to and enrollment in NSCLC clinical trials.


Criteria:

Inclusion Criteria: - All participants must be 18 years of age or older. - Patient participants must have Stage III, IV and/or recurrent NSCLC. - Patient participants must be at a point of treatment initiation/change or evaluation for treatment initiation/change - Patients must have working email address and internet access Exclusion Criteria: - Any participant who cannot understand written or spoken English. - Any participant who is not competent to provide informed consent for study participation per the investigator. - Any participant who cannot be present for the related study visits and/or complete the post-test assessment


NCT ID:

NCT02558998


Primary Contact:

Principal Investigator
Joshua Bauml, MD
Abramson Cancer Center of the University of Pennsylvania

Joshua Bauml, MD
Phone: 855-216-0098
Email: PennCancerTrials@emergingmed.com


Backup Contact:

N/A


Location Contact:

Philadelphia, Pennsylvania 19104
United States

Joshua Bauml, MD
Phone: 855-216-0098
Email: PennCancerTrials@emergingmed.com

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.